Autologous haematopoietic stem cell transplantation, or aHSCT for short, is typically used to treat blood cancers and involves collecting stem cells from the patient's own bone marrow or blood, followed by chemotherapy and antibody treatment
ICMR Director General Dr Rajiv Bahl said that no one has been so far been administered the medicine in India, further highlighting that the medicine needs to be given during the early stage of the infection.
Researchers from UCLA and the Seattle Children's Research Institute worked together to advance our understanding of the genes governing the synthesis and release of immunoglobulin G, the most prevalent class of antibody in the human body.
Thrombocytes, another name for platelets, are specialised cellular fragments that form blood clots in the event of a scrape or traumatic injury. Thrombocytopenia, is a condition recognised as decreased platelet levels throughout the body as a result of viral infections, autoimmune disease
Boston [US]/Bangalore (Karnataka) [India], August 11: Zumutor Biologics Inc "Zumutor", a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today announces that the US Food and Drug Administration (FDA) has granted the company's In
A type of monoclonal antibody that has already been tested in cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological disease.
A type of monoclonal antibody that has already been tried in certain types of cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological illness.
In recent research, researchers from the National Institutes of Health (NIH) found that infants with mitochondrial abnormalities had altered B cell activity, which led to a weaker and less diverse antibody response to viral infections. The study, published in Frontiers in Immunology, was
Researchers from the National Institutes of Health (NIH) discovered in a recent study that infants with mitochondrial abnormalities had altered B cell function, which resulted in a weaker and less varied antibody response to viral infections. Researchers at the National Human Genome Research
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.
Asthma is more hazardous than many people realise. Asthma kills over ten Americans every day, and the condition causes approximately 439,000 hospitalisations and 1.3 million emergency department visits each year.